Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
202.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.40 (0.198%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

14 Jul 2025 07:00

RNS Number : 8120Q
Ashmore Group PLC
14 July 2025
 

Ashmore Group plc14 July 2025

FOURTH QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces the following update to its assets under management ("AuM") in respect of the quarter ended 30 June 2025.

Assets under management

Theme

Actual31 March 2025

(US$ billion)

Estimated30 June 2025

(US$ billion)

Movement(%)

- External debt

7.2

7.4

+3%

- Local currency

14.0

14.2

+1%

- Corporate debt

4.9

5.2

+6%

- Blended debt

11.7

11.7

-

Fixed income

37.8

38.5

+2%

Equities

6.8

7.5

+10%

Alternatives

1.6

1.6

-

Total

46.2

47.6

+3%

 

Assets under management increased by US$1.4 billion over the period, comprising positive investment performance of US$2.2 billion and net outflows of US$0.8 billion.

Net flows improved from the prior quarter with significantly lower redemptions, against a backdrop of continuing trade tensions and geopolitical uncertainty. Subscription levels were consistent and investors' risk appetite generally remains subdued given macro events. New equity mandates were funded in the period, an impact debt strategy was launched and Ashmore opened a new office in Qatar. Overall, net flows were positive in equities, flat in external debt and alternatives, and there were net outflows in the blended debt, local currency and corporate debt themes.

Emerging markets indices delivered positive returns of between +2% and +12% over the three months, outperforming many developed markets and reflecting robust underlying fundamentals together with the impact of US dollar weakness that underpinned higher returns particularly in local currency and equities. Ashmore continues to deliver outperformance for clients across a broad range of strategies and the proportion of Group AuM outperforming benchmarks over one, three and five years has improved since the start of the calendar year.

 

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Emerging markets continue to outperform developed world equity and bond markets, in part due to the ongoing weakness in the US dollar. Consequently, investors are beginning to rebalance portfolios away from heavily overweight US positions towards more attractively valued asset classes, including those in EM. While recent EM mutual fund inflows have been concentrated in exchange traded funds, previously this has been a precursor to broader institutional behaviour.

"Ashmore's diversified product range and delivery of investment outperformance for clients means it is well-positioned to participate in the reallocation opportunity, as investors move back up to target weights and then address the structural underweights compared with EM's representation in global indices."

 

 

Notes

Local currency AuM includes US$7.9 billion of AuM managed in overlay/liquidity strategies (31 March 2025: US$7.9 billion).

For the translation of US dollar-denominated balance sheet items, the GBP:USD exchange rate was 1.3704 at 30 June 2025 (30 June 2024: 1.2641). For the translation of US dollar management fees, the average GBP:USD exchange rate for the financial year was 1.2970 (FY2024: 1.2609).

Ashmore will announce its results in respect of the year ending 30 June 2025 on 5 September 2025.

 

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278 ir@ashmoregroup.com

Cardew GroupTom Allison +44 (0)7789 998020Will Baldwin-Charles +44 (0)7834 524833 ashmore@cardewgroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLRDTILLIE
Date   Source Headline
28th May 202612:33 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTrading Statement
1st Apr 202611:05 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSAlliance
17th Mar 20263:36 pmRNSDirector/PDMR Shareholding
12th Feb 20264:25 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSHalf-year Financial Report
15th Jan 20267:00 amRNSTrading Statement
9th Dec 20252:12 pmRNSDirector/PDMR Shareholding
6th Nov 20252:34 pmRNSResult of AGM
14th Oct 20257:00 amRNSTrading Statement
9th Oct 20251:51 pmRNSHolding(s) in Company
25th Sep 20252:00 pmRNSNotice of AGM
19th Sep 20253:00 pmRNSDirector/PDMR Shareholding
19th Sep 20251:24 pmRNSDirector/PDMR Shareholding
18th Sep 202511:17 amRNSAnnual Financial Report
5th Sep 20257:00 amRNSFinal Results
14th Jul 20257:00 amRNSTrading Statement
11th Jul 20254:56 pmRNSHolding(s) in Company
30th Jun 20253:16 pmRNSDirectorate Change
23rd Jun 20252:20 pmRNSHolding(s) in Company
18th Jun 20255:18 pmRNSHolding(s) in Company
17th Jun 20254:15 pmRNSHolding(s) in Company
12th Jun 20259:36 amRNSHolding(s) in Company
10th Jun 20254:02 pmRNSHolding(s) in Company
6th Jun 20254:15 pmRNSHolding(s) in Company
6th Jun 202511:16 amRNSDirector/PDMR Shareholding
6th Jun 20259:00 amRNSHolding(s) in Company
4th Jun 20254:08 pmRNSHolding(s) in Company
27th May 20252:00 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSTrading Statement
7th Apr 20255:46 pmRNSDirector/PDMR Shareholding
31st Mar 20255:49 pmRNSDirector/PDMR Shareholding
18th Mar 202512:43 pmRNSDirector/PDMR Shareholding
18th Mar 202512:39 pmRNSDirector/PDMR Shareholding
26th Feb 20252:16 pmRNSHolding(s) in Company
26th Feb 20252:14 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNSHalf-year Report
23rd Jan 202511:54 amRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading Statement
9th Jan 202511:32 amRNSHolding(s) in Company
9th Dec 20243:47 pmRNSDirector/PDMR Shareholding
7th Nov 20245:30 pmRNSDirector/PDMR Shareholding
6th Nov 20243:01 pmRNSResult of AGM
25th Oct 20242:04 pmRNSHolding(s) in Company
14th Oct 20247:00 amRNSTrading Statement
25th Sep 20249:38 amRNSNotice of AGM
17th Sep 20242:34 pmRNSAnnual Financial Report
16th Sep 20241:37 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.